Ademi LLP is investigating CTG (Nasdaq: CTG) for possible breaches of fiduciary duty and other violations of law in its transaction with Cegeka.
In the transaction, CTG stockholders are expected to receive only $10.50 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $170 million. The transaction agreement unreasonably limits competing transactions for CTG by imposing a significant penalty if CTG accepts a competing bid. CTG insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of CTG’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.